Patent details
91908 Product Name: "Telavancine, ou un de ses sels pharmaceutiquement acceptable, y compris l'hydrochlorure de telavancine (VIBATIV®)"
Basic Information
- Publication number:
- 91908
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP019349679
- Legal Status:
- Invalid
- Application number:
- 91908
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/11/705/001-002 - VIBATIV - telavancine
- Marketing Authorization Type:
- Marketing Authorization Date:
- 02/09/2011
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
Dates
- Filing date:
- 30/11/2011
- First Marketing Authorization date:
- 02/09/2011
- Grant date:
- 30/01/2012
- Activation date:
- Publication date:
- 30/01/2012
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 01/05/2026
- SPC Extension Expiration:
- 01/05/2026
- Rejection date:
- Withdrawal date:
Owner
- From:
- 20/01/2016
- Name:
- THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
- Address:
- 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CALIFORNIA 94080, United States (US)
History of Owners
- From:
- 20/01/2016
- To:
- 20/01/2016
- Name:
- THERAVANCE, INC.
- Address:
- GATEWAY BOULEVARD 951, SOUTH SAN FRANCISCO, CA 94080, United States (US)
- From:
- 30/11/2011
- To:
- 19/01/2016
- Name:
- THERAVANCE INC.
- Address:
- 901 GATEWAY BOULEVARD, SOUTH SAN FRANCISCO, CA 94080, United States (US)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 30/11/2011
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- LEADBETTER Michael, R.
- Address:
- United States (US)
2
- Name:
- LINSELL Martin, S.
- Address:
- United States (US)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|